Treating Peritoneal Carcinomatosis With PIPAC

• Status: Completed
• Trial end date: 2017-08-01

Summary

This is a feasibility study that aims to evaluate whether PIPAC (Pressurized Intraperitoneal Aerosol Chemotherapy) is a safe and feasible treatment in Danish patients with peritoneal cancer.

• Phase: Phase 2

Details

• Lead Sponsor: Michael Bau Mortensen
• Treatments: Cisplatin; Doxorubicin; Oxaliplatin